New methods for clinical proteomics in allergy

Allergology International

Volumn 54, Issue 3, 2005, Pages 351-357

  Kato, Zenichiro ^a   Kondo, Naomi ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Clinical proteomics; High throughput screening; NMR; Protein structure; Therapeutic approach

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 8;

ALLERGY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC POLYMORPHISM; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNITY; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEOMICS; REVIEW; TH1 CELL; TH2 CELL;

EID: 25144496586     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.2332/allergolint.54.351     Document Type: Review

References (58)

1. Fajardo I, Svensson L, Bucht A, Pejler G. Increased levels of hypoxia-sensitive protein in allergic airway inflammation. Am. J. Respir. Crit. Care Med. 2004;170:477-484.
2. Beyer K, Bardina L, Grishina G, Sampson HA. Identification of sesame seed allergens by 2-dimensional proteomics and Edman sequencing: seed storage proteins as common food allergens. J. Allergy Clin. Immunol. 2002; 110:154-159.
3. Fujimura T, Shigeta S, Kawamoto S et al. Two-dimensional IgE-binding spectrum of Japanese cedar (Cryptomeria japonica) pollen allergens. Int. Arch. Allergy Immunol. 2004;133:125-135.
4. Kelso A. Cytokines and their receptors: an overview. Ther. Drug Monit. 2000;22:40-43.
5. Ohnishi H, Kato Z, Watanabe M et al. Interleukin-18 is associated with the severity of atopic dermatitis. Allergol. Int. 2003;52:123-130.
6. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 2001;12:53-72.
7. Shikano H, Kato Z, Kaneko H et al. IFN-gamma production in response to IL-18 or IL-12 stimulation by peripheral blood mononuclear cells of atopic patients. Clin. Exp. Allergy 2001;31:1263-1270.
8. Kondo N, Matsui E, Kaneko H et al. Reduced interferon-gamma production and mutations of the interleukin-12 receptor beta (2) chain gene in atopic subjects. Int. Arch. Allergy Immunol. 2001;124:117-120.
9. de Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin. Diagn. Lab Immunol. 2003;10:133-139.
10. Swartzman EE, Miraglia SJ, Mellentin-Michelotti J, Evangelista L, Yuan PM. A homogeneous and multiplexed immunoassay or high-throughput screening using fluorometric microvolume assay technology. Anal. Biochem. 1999; 271:143-151.
11. Oliver DG, Sanders AH, Hogg RD, Hellman JW. Thermal gradients in microtitration plates. Effects on enzyme-linked immunoassay. J. Immunol. Methods 1981;42:195-201.
12. Shekarchi IC, Sever JL, Lee YJ, Castellano G, Madden DL. Evaluation of various plastic microtiter plates with measles, toxoplasma, and gamma globulin antigens in enzyme-linked immunosorbent assays. J. Clin. Microbiol. 1984;19:89-96.
13. Schapira M, Raaka BM, Das S et al. Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking. Proc. Natl. Acad. Sci. U.S.A. 2003; 100:7354-7359.
14. Morokata T, Ida K, Yamada T. Characterization of YM-90709 as a novel antagonist which inhibits the binding of interleukin-5 to interleukin-5 receptor. Int. Immunopharmacol. 2004;4:873-883.
15. Oelschlaeger P, Srikant-Iyer S, Lange S, Schmitt J, Schmid RD. Fluorophor-linked immunosorbent assay: a time- and cost-saving method for the characterization of antibody fragments using a fusion protein of a single-chain antibody fragment and enhanced green fluorescent protein. Anal. Biochem. 2002;309:27-34.
16. Dietz LJ, Dubrow RS, Manian BS, Sizto NL. Volumetric capillary cytometry: a new method for absolute cell enumeration. Cytometry 1996;23:177-186.
17. Melletin-Michelotti J, Evangelista LT, Swartzman EE, Miraglia SJ, Werner WE, Yuan PM. Determination of ligand binding affinities for endogenous seven-transmembrane receptors using fluorometric microvolume assay technology. Anal. Biochem. 1999;272:182-190.
18. Martens C, Bakker A, Rodriguez A et al. A generic particle-based nonradioactive homogeneous multiplex method for high-throughput screening using microvolume fluorimetry. Anal. Biochem. 1999;273:20-31.
19. Miraglia S, Swartman EE, Mellentin-Michelotti J et al. Homogeneous Cell- and Bead-Based Assays for High Throughput Screening Using Fluorometric Microvolume Assay Technology. J. Biomol. Screen 1999;4:193-204.
20. Lee JY, Miraglia S, Yan X et al. Oncology drug discovery applications using the FMAT 8100 HTS system. J. Biomol. Screen 2003;8:81-88.
21. Okamura H, Tsutsui H, Komatsu T et al. Cloning of a new cytokine that induces IFN-g production by T-cells. Nature 1995;378:88-91.
22. Ushio S, Namba M, Okura T et al. Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic actives of the protein. J. Immunol. 1996; 156:4274-4279.
23. Shikano H, Kato Z, Kaneko H et al. IFN-gamma production in response to IL-18 or IL-12 stimulation by peripheral blood mononuclear cells of atopic patients. Clin. Exp. Allergy 2001;31:1263-1270.
24. Watanabe M, Kaneko H, Shikano H et al. Predominant expression of 950delCAG of IL-18R alpha chain cDNA is associated with reduced IFN-gamma production and high serum IgE levels in atopic Japanese children. J. Allergy Clin. Immunol. 2002;109:669-675.
25. Kato Z, Jee J, Shikano H et al. The structure and binding mode of interleukin-18. Nature Struct. Biol. 2003;10:966-971.
26. Omoya K, Kato Z, Matsukuma E et al. Systemic optimization of active protein expression using GFP as a folding reporter. Protein Expr. Purif. 2004;36:327-332.
27. Li A, Kato Z, Ohnishi H et al. Optimized gene synthesis and high expression of human interleukin-18. Protein Expr. Purifi. 2003;32:110-118.
28. Cavanagh J, Fairbrother WJ, Palmer AG III, Skelton NJ. Protein NMR Spectroscopy. San Diego: Academic Press, 1996.
29. Hu W, Zuiderweg ER. Stereospecific assignments of Val and Leu methyl groups in a selectively 13C-labeled 18kDa polypeptide using 3D CT-(H)CCH-COSY and 2D 1JC-C edited heteronuclear correlation experiments. J. Magn. Reson. 1996;113:70-75.
30. Guentert P, Mumenthaler C, Wuethrich K. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J. Mol. Biol. 1997;273:283-298.
31. Cornilescu G, Delaglio F, Bax A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR. 1999;13:289-302.
32. Hu JS, Grzesiek S, Bax A. Two-dimensional NMR methods for determining c1 angles of aromatic residues in proteins from three bond JC'Cg and JNCg couplings. J. Am. Chem. Soc. 1997;119:1803-1804.
33. Herrmann T, Guntert P, Wuethrich K. Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J. Mol. Biol. 2002;319:209-227.
34. Brunger AT, Adams PD, Clore GM et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallog. D. 1998;54: 905-921.
35. Koradi R, Billeter M, Wuethrich K. MOLMOL: a program for the display and analysis of macromolecular structures. J. Mol. Graph. 1996;14:51-55.
36. Laskowski RA, Rullman JAC, MacArthur MW, Kaptein R, Thornton JM. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 1996;8:477-486.
37. Chemical Computing Group Inc. MOE: The Molecular Operating Environment. Montreal: 1999.
38. Case DA. AMBER 5. San Francisco: University of California, 1997.
39. Vigers GP, Anderson LJ, Caffes P, Brandhuber BJ. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta. Nature 1997;386:190-194.
40. Schreuder H, Tardif C, Trump-Kallmeyer S et al. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature 1997;386:194-200.
41. Bazan JF, Timans JC, Kastelein RA A newly defined interleukin-1? Nature 1996;379:591.
42. Konishi K, Tanabe F, Taniguchi M et al. A simple and sensitive bioassay for the detection of human interleukin-18/interferon-g-inducing factor using human myelomonocytic KG-1 cells. J. Immunol. Methods 1997;209:187-191.
43. Evans RJ, Bray J, Childs JD et al. Mapping receptor binding sites in interleukin (IL)-receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta. J. Biol. Chem. 1995;270:11477-11483.
44. Kim SH, Azam T, Novick D et al. Identification of amino acid residues critical for biological activity in human interleukin-18. J. Biol. Chem. 2002;277:10998-11003.
45. Born TL, Thomassen E, Bird TA, Sims JE. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J. Biol. Chem. 1998;273:29445-29450.
46. DeVos AM, Ultsch M, Kossiakoff AA. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 1992;255:306-312.
47. Wiesmann C, de Vos AM. Variations on ligand-receptor complexes. Nat. Struct. Biol. 2000;7:440-442.
48. Wells JA, de Vos AM. Hematopoietic receptor complexes. Annu. Rev. Biochem. 1996;65:609-634.
49. Hage T, Sebald W, Reinemer P. Crystal structure of the interleukin-4/receptor alpha chain complex reveals a mosaic binding interface. Cell 1999;97:271-281.
50. Schlessinger J, Plotnikov AN, Ibrahimi OA et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell 2000;6:743-750.
51. Auron PE. The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine Growth Factor Rev. 1998;9:221-237.
52. Entrez SNP. Available from web: http: //www.ncbi.nlm. nih.gov/entrez/query.fcgi?db=Snp.
53. Kumar S, McDonnell PC, Lehr R et al. Identification and initial characterization of four novel members of the interleukin-1 family. J. Biol. Chem. 2000;275:10308-10314.
54. Born TL, Smith DE, Garka KE, Renshaw BR, Bertles JS, Sims JE. Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. J. Biol. Chem. 2000;275:29946-29954.
55. Kim SH, Eisenstein M, Reznikov L et al. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc. Natl. Acad. Sci. U. S.A. 2000;97:1190-1195.
56. Xiang Y, Moss B. Determination of the functional epitopes of human interleukin-18-binding protein by site-directed mutagenesis. J. Biol. Chem. 2001;276:17380-17386.
57. Yamamoto Y, Kato Z, Matsukuma E et al. Generation of highly stable IL-18 based on a ligand-receptor complex structure. Biochem. Biophys. Res. Commun. 2004;317: 181-186.
58. Vigers GP, Dripps DJ, Edwards CK 3rd, Brandhuber BJ. X-ray crystal structure of a small antagonist peptide bound to interleukin-1 receptor type 1. J. Biol. Chem. 2000;275:36927-36933.